10x Genomics (TXG) Short term Debt (2018 - 2019)
10x Genomics (TXG) reported Short term Debt of $9.9 million for Q4 2019, up 136.02% on a YoY basis from $4.2 million in Q4 2018, and up 33.85% sequentially from $7.4 million in Q3 2019.
10x Genomics (TXG) Short term Debt (2018 - 2019) Analysis & Trends
10x Genomics (TXG) has 2 years of Short term Debt data on file, last reported at $9.9 million in Q4 2019.
- For the quarter ending Q4 2019, Short term Debt rose 136.02% year-over-year to $9.9 million; the trailing twelve-month figure through Dec 2019 stood at $9.9 million (up 136.02% YoY), and the FY2019 full-year result was $9.9 million, up 136.02% from the prior year.
- Short term Debt climbed to $9.9 million in Q4 2019, from $7.4 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $9.9 million in Q4 2019 to a low of $4.2 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 32.17 Bn | 24.85 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.60 Bn | 13.70 Bn | 482.22 Mn |
| 3 | Healthequity | 8.41 Bn | 8.14 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.96 Bn | 5.64 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.86 Bn | 5.32 Bn | 106.18 Mn |
| 6 | MiniMed | 4.51 Bn | 4.21 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.47 Bn | 4.40 Bn | 216.84 Mn |
| 8 | Doximity | 3.95 Bn | 3.21 Bn | 125.97 Mn |
| 9 | Privia Health | 3.12 Bn | 2.70 Bn | - |
| 10 | Omnicell | 1.88 Bn | 1.64 Bn | 140.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 9.88 Mn |
| Sep 30, 2019 | 7.38 Mn |
| Dec 31, 2018 | 4.19 Mn |